XING

Haybury

60 followers

11-50 employees

News

Show all news

Hayburyposted an update•28 February 2019

Immatics, Roche ally to trial Tecentriq with cell therapy https://bit.ly/2U9zMMj

Immatics, Roche ally to trial Tecentriq with cell therapy

Immatics has struck a deal to test its autolog | Immatics has struck a deal to test its autologous cell therapy in combination with Roche’s checkpoint inhibitor Tecentriq. The clinical collaboration clears Immatics to test whether Roche’s antibody boosts the efficacy of its IMA101 in solid tumors.www.fiercebiotech.com

Hayburyposted an update•28 February 2019

Syncona, Novartis back IL-2 immuno-oncology startup Anaveon https://bit.ly/2BWX8hd

Syncona, Novartis back IL-2 immuno-oncology startup Anaveon

Syncona and Novartis have invested in Anaveon. | Syncona and Novartis have invested in Anaveon. The $35 million series A round sets Anaveon up to advance a preclinical asset designed to enhance anti-tumor immune responses. www.fiercebiotech.com

Hayburyposted an update•27 February 2019

Boehringer Ingelheim appoints new chief medical officer https://bit.ly/2VsNQRB

Boehringer Ingelheim appoints new chief medical officer

Boehringer Ingelheim has announced the appointment of Dr Mehdi Shahid as chief medical officer.www.pharmatimes.com

Show all news

Similar companies

Dierichs Druck + Media GmbH & Co. KG

29 employer ratings on Kununu

4.2

Karl Knauer KG

49 employer ratings on Kununu

3.2

apm alpha print medien AG

16 employer ratings on Kununu

3.4

About us

Show more

Haybury are an Executive Search Consultancy who are committed to providing solutions and creating opportunities through innovation and collaboration. We focus solely within Life Sciences, working to place key people in key positions across leading pharmaceutical and biotech companies, CROs and start-ups. Our roles are...